Patent Invalidity Claim. Each Party shall promptly notify the other in the event of any legal action (excluding any actions covered by Section 7.3) by any Third Party with respect to the validity of a MedImmune Patent, MedImmune Additional Patent, Kolltan Patent or Joint Patent of which it becomes aware. With respect to any such action:
Appears in 3 contracts
Samples: License and Option Agreement (Celldex Therapeutics, Inc.), License and Option Agreement (Kolltan Pharmaceuticals Inc), License and Option Agreement (Kolltan Pharmaceuticals Inc)
Patent Invalidity Claim. Each Party shall promptly notify the other in the event of any legal action (excluding any actions covered by Section 7.39.3) by any Third Party with respect to the validity of a MedImmune Joint Patent, MedImmune Additional Patent, Kolltan MacroGenics Patent or Joint Gilead Collaboration Patent of which it becomes aware. With respect to any such action:
Appears in 2 contracts
Samples: License Agreement (Macrogenics Inc), License Agreement (Macrogenics Inc)
